1h Free Analyst Time
The Blood Testing Market size was estimated at USD 94.49 billion in 2023, USD 100.02 billion in 2024, and is expected to grow at a CAGR of 6.34% to reach USD 145.37 billion by 2030. Speak directly to the analyst to clarify any post sales queries you may have.
Blood testing is a clinical procedure that involves analyzing a blood sample in a laboratory to assess the general state of health, detect the presence of viral or bacterial infections, determine the functioning of various organs, and screen for genetic conditions. Blood tests are critical tools for preventive medicine and medical diagnostics, providing valuable data for early disease detection and management. Blood tests have various applications in various medical and healthcare domains. Routine testing for metabolic functions, increasing prevalence of infectious disease, and ongoing investments in blood testing facilities have enhanced the need for advanced blood testing solutions. However, strict regulatory requirements for approval and high costs associated with advanced testing technologies may restrict product penetration worldwide. In addition, a lack of trained professionals to conduct and interpret complex blood tests may limit the use of blood testing solutions. Nevertheless, the improved testing technologies that provide quicker, more accurate, and less invasive testing and Increased spending on healthcare infrastructure and diagnostics are expected to create growth opportunities for the blood testing market in the coming years.
Regional Insights
The blood testing market in the Americas is highly developing and characterized by advanced healthcare systems and higher consumer awareness of health conditions. A growing prevalence of chronic diseases, an aging population, and the presence of major healthcare companies elevate the need for diagnostic services such as blood testing. European Union (EU) countries exhibit a strong need for blood testing due to the high healthcare standards and the presence of national healthcare systems. An increasing focus on preventive care and the prevalence of chronic diseases among aging populations drives the market. Furthermore, the EU's stringent regulatory framework ensures high-quality blood testing procedures and equipment standards. The Middle East showcases rapid advancement due to investments in healthcare infrastructure, while many African regions face challenges, including accessibility and affordability of blood testing products. The Asia Pacific region represents a rapidly growing blood testing market due to large population bases, increasing healthcare expenditures, and rapid urbanization. The ongoing innovation and development of consumer-friendly blood testing products are expected to drive the blood testing market in Asia-Pacific.FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Blood Testing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Blood Testing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.Key Company Profiles
The report delves into recent significant developments in the Blood Testing Market, highlighting leading vendors and their innovative profiles. These include A. Menarini Diagnostics s.r.l., Abbott Laboratories, ACON Laboratories, Inc., ARKRAY, Inc., B. Braun Melsungen AG, Becton Dickinson & Company, Bio-Rad Laboratories Inc., bioMérieux S.A., Danaher Corporation, F. Hoffmann-La Roche AG, Johnson & Johnson Services, Inc., Medtronic PLC, Merck KGaA, Nipro Corporation, Nova Biomedical Corporation, Novo Nordisk A/S, Omnipod by Insulet Corporation, Quest Diagnostic, Randox Laboratories Ltd., Siemens AG, Terumo Corporation, Thermo Fisher Scientific, Inc., Trinity Biotech PLC, Trividia Health, Inc., and Ypsomed AG.Market Segmentation & Coverage
This research report categorizes the Blood Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:- Type
- Basic Metabolic Panels
- Complete Blood Count Tests
- Complete Metabolic Panels
- Electrolyte Panels
- Application
- Allergies
- Autoimmune Diseases
- Cancer/Noncancerous Blood Disorders
- Endocrine System Disorders
- Heart Diseases
- End-User
- Home Care
- Hospital & Clinics
- Region
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
- Americas
The report offers valuable insights on the following aspects:
- Market Penetration: It presents comprehensive information on the market provided by key players.
- Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
- Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
- Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
- Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
- What is the market size and forecast of the Blood Testing Market?
- Which products, segments, applications, and areas should one consider investing in over the forecast period in the Blood Testing Market?
- What are the technology trends and regulatory frameworks in the Blood Testing Market?
- What is the market share of the leading vendors in the Blood Testing Market?
- Which modes and strategic moves are suitable for entering the Blood Testing Market?
With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.
This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.
Table of Contents
1. Preface1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Blood Testing Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Prevalence of autoimmune disorders among individuals and need for enhanced care
5.1.1.2. Government initiatives in blood testing checkup campaigns
5.1.1.3. Significant expansion of blood testing facilities worldwide
5.1.2. Restraints
5.1.2.1. Changing costs of raw materials and issues of product recalls
5.1.3. Opportunities
5.1.3.1. Rapid adoption of home-based healthcare and telemedicine
5.1.3.2. Advancements in blood testing products
5.1.4. Challenges
5.1.4.1. Inaccuracy in skin puncture and safety issues associated with blood testing products
5.2. Market Segmentation Analysis
5.2.1. Type: Significant penetration of basic metabolic panels for blood testing
5.2.2. Application: Rising usage of blood testing kits for diagnosis of autoimmune diseases
5.2.3. End-User: Emerging penetration of blood testing products in home care settings
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Blood Testing Market, by Type
6.1. Introduction
6.2. Basic Metabolic Panels
6.3. Complete Blood Count Tests
6.4. Complete Metabolic Panels
6.5. Electrolyte Panels
7. Blood Testing Market, by Application
7.1. Introduction
7.2. Allergies
7.3. Autoimmune Diseases
7.4. Cancer/Noncancerous Blood Disorders
7.5. Endocrine System Disorders
7.6. Heart Diseases
8. Blood Testing Market, by End-User
8.1. Introduction
8.2. Home Care
8.3. Hospital & Clinics
9. Americas Blood Testing Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Blood Testing Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Blood Testing Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
12.3.1. Merger & Acquisition
12.3.1.1. Bert Vogelstein’s Latest Blood Testing Startup Gets Acquired for USD 450 Million
12.3.2. Agreement, Collaboration, & Partnership
12.3.2.1. Diagnostics Companies Enter Agreement to Expand Access to Blood-Based IsoPSA Test
12.3.3. New Product Launch & Enhancement
12.3.3.1. Labcorp Launches 3-Part Blood Test for Alzheimer's
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. A. Menarini Diagnostics s.r.l.
13.1.2. Abbott Laboratories
13.1.3. ACON Laboratories, Inc.
13.1.4. ARKRAY, Inc.
13.1.5. B. Braun Melsungen AG
13.1.6. Becton Dickinson & Company
13.1.7. Bio-Rad Laboratories Inc.
13.1.8. bioMérieux S.A.
13.1.9. Danaher Corporation
13.1.10. F. Hoffmann-La Roche AG
13.1.11. Johnson & Johnson Services, Inc.
13.1.12. Medtronic PLC
13.1.13. Merck KGaA
13.1.14. Nipro Corporation
13.1.15. Nova Biomedical Corporation
13.1.16. Novo Nordisk A/S
13.1.17. Omnipod by Insulet Corporation
13.1.18. Quest Diagnostic
13.1.19. Randox Laboratories Ltd.
13.1.20. Siemens AG
13.1.21. Terumo Corporation
13.1.22. Thermo Fisher Scientific, Inc.
13.1.23. Trinity Biotech PLC
13.1.24. Trividia Health, Inc.
13.1.25. Ypsomed AG
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. BLOOD TESTING MARKET RESEARCH PROCESS
FIGURE 2. BLOOD TESTING MARKET SIZE, 2023 VS 2030
FIGURE 3. BLOOD TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. BLOOD TESTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. BLOOD TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. BLOOD TESTING MARKET DYNAMICS
FIGURE 7. BLOOD TESTING MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. BLOOD TESTING MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. BLOOD TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. BLOOD TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. BLOOD TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. BLOOD TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS BLOOD TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS BLOOD TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES BLOOD TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES BLOOD TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC BLOOD TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC BLOOD TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BLOOD TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BLOOD TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. BLOOD TESTING MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. BLOOD TESTING MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. BLOOD TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. BLOOD TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BLOOD TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. BLOOD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 6. BLOOD TESTING MARKET SIZE, BY BASIC METABOLIC PANELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. BLOOD TESTING MARKET SIZE, BY COMPLETE BLOOD COUNT TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. BLOOD TESTING MARKET SIZE, BY COMPLETE METABOLIC PANELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. BLOOD TESTING MARKET SIZE, BY ELECTROLYTE PANELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 11. BLOOD TESTING MARKET SIZE, BY ALLERGIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. BLOOD TESTING MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. BLOOD TESTING MARKET SIZE, BY CANCER/NONCANCEROUS BLOOD DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. BLOOD TESTING MARKET SIZE, BY ENDOCRINE SYSTEM DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. BLOOD TESTING MARKET SIZE, BY HEART DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 17. BLOOD TESTING MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. BLOOD TESTING MARKET SIZE, BY HOSPITAL & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS BLOOD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS BLOOD TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 23. ARGENTINA BLOOD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 24. ARGENTINA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 26. BRAZIL BLOOD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 27. BRAZIL BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 28. BRAZIL BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 29. CANADA BLOOD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 30. CANADA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 31. CANADA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 32. MEXICO BLOOD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 33. MEXICO BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 34. MEXICO BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES BLOOD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES BLOOD TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 39. ASIA-PACIFIC BLOOD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 40. ASIA-PACIFIC BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 41. ASIA-PACIFIC BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 42. ASIA-PACIFIC BLOOD TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 43. AUSTRALIA BLOOD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 44. AUSTRALIA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 45. AUSTRALIA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 46. CHINA BLOOD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 47. CHINA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 48. CHINA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 49. INDIA BLOOD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 50. INDIA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 51. INDIA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 52. INDONESIA BLOOD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 53. INDONESIA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 54. INDONESIA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 55. JAPAN BLOOD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 56. JAPAN BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 57. JAPAN BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 58. MALAYSIA BLOOD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 59. MALAYSIA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 60. MALAYSIA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 61. PHILIPPINES BLOOD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 62. PHILIPPINES BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 63. PHILIPPINES BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 64. SINGAPORE BLOOD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 65. SINGAPORE BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. SINGAPORE BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 67. SOUTH KOREA BLOOD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 68. SOUTH KOREA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. SOUTH KOREA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 70. TAIWAN BLOOD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 71. TAIWAN BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. TAIWAN BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 73. THAILAND BLOOD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 74. THAILAND BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. THAILAND BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 76. VIETNAM BLOOD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 77. VIETNAM BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 78. VIETNAM BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA BLOOD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA BLOOD TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 83. DENMARK BLOOD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 84. DENMARK BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 85. DENMARK BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 86. EGYPT BLOOD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 87. EGYPT BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. EGYPT BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 89. FINLAND BLOOD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 90. FINLAND BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 91. FINLAND BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 92. FRANCE BLOOD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 93. FRANCE BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. FRANCE BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 95. GERMANY BLOOD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 96. GERMANY BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. GERMANY BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 98. ISRAEL BLOOD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 99. ISRAEL BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 100. ISRAEL BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 101. ITALY BLOOD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 102. ITALY BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 103. ITALY BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 104. NETHERLANDS BLOOD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 105. NETHERLANDS BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 106. NETHERLANDS BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 107. NIGERIA BLOOD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 108. NIGERIA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. NIGERIA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 110. NORWAY BLOOD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 111. NORWAY BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 112. NORWAY BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 113. POLAND BLOOD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 114. POLAND BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 115. POLAND BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 116. QATAR BLOOD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 117. QATAR BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 118. QATAR BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA BLOOD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 120. RUSSIA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 121. RUSSIA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 122. SAUDI ARABIA BLOOD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 123. SAUDI ARABIA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 124. SAUDI ARABIA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 125. SOUTH AFRICA BLOOD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 126. SOUTH AFRICA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 127. SOUTH AFRICA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 128. SPAIN BLOOD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 129. SPAIN BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 130. SPAIN BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 131. SWEDEN BLOOD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 132. SWEDEN BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 133. SWEDEN BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 134. SWITZERLAND BLOOD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 135. SWITZERLAND BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. SWITZERLAND BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 137. TURKEY BLOOD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 138. TURKEY BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. TURKEY BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 140. UNITED ARAB EMIRATES BLOOD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 141. UNITED ARAB EMIRATES BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. UNITED ARAB EMIRATES BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM BLOOD TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 146. BLOOD TESTING MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 147. BLOOD TESTING MARKET SHARE, BY KEY PLAYER, 2023
TABLE 148. BLOOD TESTING MARKET LICENSE & PRICING
Companies Mentioned
- A. Menarini Diagnostics s.r.l.
- Abbott Laboratories
- ACON Laboratories, Inc.
- ARKRAY, Inc.
- B. Braun Melsungen AG
- Becton Dickinson & Company
- Bio-Rad Laboratories Inc.
- bioMérieux S.A.
- Danaher Corporation
- F. Hoffmann-La Roche AG
- Johnson & Johnson Services, Inc.
- Medtronic PLC
- Merck KGaA
- Nipro Corporation
- Nova Biomedical Corporation
- Novo Nordisk A/S
- Omnipod by Insulet Corporation
- Quest Diagnostic
- Randox Laboratories Ltd.
- Siemens AG
- Terumo Corporation
- Thermo Fisher Scientific, Inc.
- Trinity Biotech PLC
- Trividia Health, Inc.
- Ypsomed AG
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 184 |
| Published | March 2024 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 100.02 Billion |
| Forecasted Market Value ( USD | $ 145.37 Billion |
| Compound Annual Growth Rate | 6.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 25 |
